Skip to main content
Sister Publication Links
  • ModernHealthcare.com
Subscribe
  • My Account
  • Login
  • Register
  • Consumer Centric
  • Provider/Payer Centric
  • Funding/M&A
  • Policy
  • Data
  • Opinion
  • MORE+
    • Webinars
    • Advertise
MENU
Breadcrumb
  1. Home
  2. Technology
January 24, 2023 03:01 AM

Amazon rolls out generic drug subscription service

Brock E.W. Turner
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Amazon RxPass
    Amazon

    Amazon is expanding its push into healthcare with the introduction of a generic drug subscription service aimed at consumers with common conditions like high blood pressure, acid reflux or anxiety.

    The medication delivery service, RxPass, costs $5 per month for Amazon Prime members. Amazon Prime costs either $14.99 per month or $139 annually. 

    The service, announced Tuesday, starts immediately in most states except California, Louisiana, Maryland, Minnesota, New Hampshire, Pennsylvania, Texas and Washington because of state-specific requirements. Dr. Vin Gupta, chief medical officer of Amazon Pharmacy, said there are approximately 50 generic medications treating 80 health conditions available on the subscription list. 

    RxPass will target people with chronic conditions who require multiple prescription medications and pay for them out-of-pocket, said John Love, vice president at Amazon Pharmacy. Love said the lack of pricing transparency around prescription medications drove the company’s decision to start the service. 

    "The bulk of scripts Americans get are administered the same way they have been for decades,” Love said. "The patient drives [to the pharmacy], they stand in a communal environment...and they find out the price at the point of care.” 

    While a full list of medications was not immediately available, RxPass will cover a range of hypertensives for high blood pressure and Venlafaxine for anxiety and depression. 

    The service is not available to anyone enrolled in Medicare, Medicaid, or any other government healthcare program because those people have a $0 copay, Love said. RxPass will use the company’s existing pharmacy infrastructure and distribution channels, he said. 

    RxPass is the latest salvo from the big tech company in the pharmacy space through its Amazon Pharmacy subsidiary. In 2018, the company bought online pharmacy company PillPack for $750 million. It also partnered with multiple Blue Cross and Blue Shield plans to provide medications through home delivery. And it rolled out PrimeRx in late 2020, allowing people to compare the prices of medications and offers potential savings. 

    Amazon works with Inside Rx, a prescription drug pricing comparison service owned by Express Scripts, to administer RxPass and PrimeRx.  

    ScriptCo pharmacy, a membership-based pharmacy company, offers a similar service to RxPass for an annual fee of $140. 

    In the last few years, generic medications have become a focal area for startups and industry disrupters.

    A group of health systems and philanthropic organizations launched nonprofit Civica Rx in 2018 to make generic medications more widely available. In March 2022, the nonprofit said it was planning to produce insulin that will be available at lower prices, making it more accessible to people with diabetes. 

    Entrepreneur Mark Cuban co-founded a mail order pharmacy service called The Mark Cuban Cost Plus Drug Co., which works with drug manufacturers to offer generic drugs at fixed-rate markups. It partnered with EmansaRx, the pharmacy benefit manager spun out of the Purchaser Business Group on Health, in December to provide discounted prescription drugs to self-insured employers.  

    As Amazon waits for federal approval of its proposed $3.9 billion acquisition of One Medical, the tech giant furthered its investment with the launch of Amazon Clinic in November. 

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it online.

    Recommended for You
    AMN Stand 3.0 with Pregnant-2-Full REZ-2 (5).jpg
    Medical interpreters face high demand, low reimbursement
    Palantir_Technologies_Logo_i.jpg
    Cleveland Clinic enters multiyear partnership with Palantir Technologies
    Sponsored Content
    Get Newsletters

    Newsletters for providers, payers, investors and innovators across the digital health ecosystem. Sign up to get breaking digital health news including digital health deals, M&A, finance, IPOs. as they happen, right to your inbox.

    Buy Q3 Report Today
    Quarterly Report Cover Image

    The Digital Health Funding and M&A Q3 report delivers the most comprehensive insight and data around the financial health of the sector.

    Purchase Today
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Digital Health Business & Technology delivers news, data, insights and analysis covering the entire digital healthcare ecosystem.

    Logo
    Contact Us

    (877) 812-1581

    Email us

     

    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    Resources
    • About Us
    • Contact Us
    • Staff
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Digital Health Business & Technology
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • Consumer Centric
    • Provider/Payer Centric
    • Funding/M&A
    • Policy
    • Data
    • Opinion
    • MORE+
      • Webinars
      • Advertise